 
 
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: AL-001 | AL001
                                 Compound class: 
                                                            Antibody
                                 
                                    
                                        Comment: Latozinemab (AL001) is an anti-sortilin 1 (SORT1) monoclonal antibody. It is proposed to elevate progranulin levels by inhibiting the SORT1-mediated degradation pathway for progranulin (PGRN). This mechanism is being investigated as a disease‐modifying therapy for patients with frontotemporal dementia caused by loss-of-function mutations in GRN.
                                    
                                 | 
| Classification  | |
| Compound class | Antibody | 
| International Nonproprietary Names  | |
| INN number | INN | 
| 11584 | latozinemab | 
| Synonyms  | 
| AL-001 | AL001 | 
| Database Links  | |
| Specialist databases | |
| IMGT/mAb-DB | 1130 | 
| Other databases | |
| GtoPdb PubChem SID | 507750319 | 
| Search PubMed clinical trials | latozinemab | 
| Search PubMed titles | latozinemab | 
| Search PubMed titles/abstracts | latozinemab |